Abstract

Purpose of reviewTo review recent published literature around three areas: long-term nonprogression/viral control; predictors of viral load set point/disease progression; and the potential impact of antiretroviral therapy (ART) in early HIV infection.Recent findingsThe natural course of untreated HIV infection varies widely with some HIV-positive individuals able to maintain high CD4 cell counts and/or suppressed viral load in the absence of ART. Although similar, the underlying mechanistic processes leading to long-term nonprogression and viral control are likely to differ. Concerted ongoing research efforts will hopefully identify host factors that are causally related to these phenotypes, thus providing opportunities for the development of novel treatment or preventive strategies. Although there is increasing evidence that initiation of ART during primary infection may prevent the immunological deterioration which would otherwise be seen in untreated HIV infection, recent studies do not address the longer term clinical benefits of ART at this very early stage.SummaryA better understanding of the relative influences of viral, host, and environmental factors on the natural course of HIV infection has the potential to identify novel targets for intervention to prevent and treat HIV-infected persons.

Highlights

  • In the early days of the HIV epidemic, knowledge about the natural history of HIV accrued rapidly

  • For the purposes of this review, we will focus on three areas of relevance to treating clinicians: long-term nonprogression and viral control; predictors of viral load set point and disease progression; and the potential impact of antiretroviral therapy (ART) in early HIV infection

  • Host defence responses, and environmental factors may all contribute to the variation in the natural course of HIV infection

Read more

Summary

INTRODUCTION

In the early days of the HIV epidemic, knowledge about the natural history of HIV accrued rapidly. It is widely reported that 1–5% of the HIV-positive population are LTNP, these estimates are complicated by the fact that there is no standardized definition of a LTNP, and aResearch Department of Infection and Population Health, University College London (UCL), Royal Free Campus, London, UK and bDepartDepartment of Infectious Diseases, Copenhagen University Hospital/ Rigshospitalet and Copenhagen HIV Programme, University of Copenhagen, Copenhagen, Denmark. 1746-630X ß 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins www.co-hivandaids.com

KEY POINTS
Findings
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call